# FDA Inspection 1299590 - Mission Medical Distribution - January 07, 2026

Source: https://www.keypedia.com/records/fda_inspections/mission-medical-distribution/027f38d4-4908-4ace-ba65-5b1841ecfa83
Source feed: FDA_Inspections

> FDA Inspection 1299590 for Mission Medical Distribution on January 07, 2026. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1299590
- Company Name: Mission Medical Distribution
- Inspection Date: 2026-01-07
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics

## Related Documents

- [FDA Inspection 1299590 - 2026-01-07](https://www.keypedia.com/records/fda_inspections/mission-medical-distribution/a99ad3f9-3476-4a41-8d34-26478680ef48)
- [FDA Inspection 1078126 - 2019-01-30](https://www.keypedia.com/records/fda_inspections/mission-medical-distribution/8f2e9784-5d49-4980-bc1f-0f635a6431c1)
- [FDA Inspection 919434 - 2015-03-24](https://www.keypedia.com/records/fda_inspections/mission-medical-distribution/f28fa365-e552-44b2-af28-f3210d698942)
- [FDA Inspection 798336 - 2012-09-12](https://www.keypedia.com/records/fda_inspections/mission-medical-distribution/95c16df4-5909-4bd5-af72-1b0b65bf3f60)

Company: https://www.keypedia.com/companies/mission-medical-distribution/a86bbb23-e409-4d0a-8187-93d7aada1007